Dr. Amir Ravandi received an undergraduate degree in Biochemistry from the University of Toronto and went on to complete a Ph.D. at the Banting and Best Medical Research Institute at the University of Toronto. He was at the Terrence Donnelly Vascular Research Labs at St. Michael’s Hospital as a postdoctoral fellow. After obtaining his MD at the University of Toronto, he went on to complete internal medicine and cardiology training at McMaster University. He completed a fellowship in coronary and peripheral vascular interventions at the University of California at San Diego. He is currently a clinician-scientist at the University of Manitoba, is on the staff at St. Boniface Hospital as an interventional cardiologist, and is the Research Director for the Section of Cardiology at the University of Manitoba. He is an associate professor at the University of Manitoba and has been the recipient of the MMSF Duval Clinical Research Professorship. He is a principal investigator at the Institute of Cardiovascular Sciences, and his current focus is to identify the contribution of bioactive lipids to cardiac muscle injury during acute myocardial infarction utilizing lipidomics. The ultimate goal is to not only identify the contribution of bioactive lipids to cardiac muscle injuries but also to determine new therapeutic approaches to prevent the pathological effects of oxidized lipids.